August 3, 2026

---

Vilmorin & Cie and Qi Biodesign: worldwide licensing agreement for genome editing technologies
Vilmorin & Cie et Qi Biodesign : signature d'un accord mondial de licence pour des technologies d'édition du génome

January 14, 2025

---

Qi Biodesign completes $75 million in total funding to drive genome editing innovations (AgroSpectrum)

May 30, 2024

---

USDA/APHIS issues Regulatory Status Review responses

June 8, 2023

---

Qi-Biodesign announces the appointment of Dr. Bei Zhang as the company’s Chief Executive Officer

April 20, 2023

---

Accelerating the research and application of gene editing technology, Qi-Biodesign has successfully completed a Pre-A round financing of over 100 million yuan

September 19, 2022

---

Build SEEDIT Platform to accelerate the strategic layout of research and development